No Data
No Data
Haitong Int'l: active investment and financing market, CRO companies accelerate layout of AI+pharmaceutical application technology.
With the continuous advancement of AI technology and the enhanced professional capabilities of CRO companies, it is expected that there will be more innovative breakthroughs in the field of drug research and development in the future.
Evolving DNA-Encoded Library Technology and Its Application for Innovative Drug Discovery, Upcoming Webinar Hosted by HitGen and Xtalks
Is HitGen Inc. (SHSE:688222) Worth CN¥10.8 Based On Its Intrinsic Value?
Hitgen Inc. (688222.SH) plans to distribute 0.05 yuan per share in 2023, with ex-right and ex-dividend on June 21st.
Hitgen Inc. (688222.SH) announced its annual equity distribution plan for 2023: to distribute 10 yuan (tax inclusive) for every 10 shares to all shareholders and reserve the remaining undistributed profits over the years.
We Think HitGen (SHSE:688222) Can Manage Its Debt With Ease
Chengdu Pilot (688222.SH): The transfer price in this inquiry is 11.26 yuan/share
On May 20, Ge Longhui | Chengdu Pilot (688222.SH) announced that according to the inquiry and subscription situation on May 17, 2024, the initial confirmed transfer price of the inquiry was 11.26 yuan/share.
No Data